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Abstract
A novel coronavirus recently identified in Wuhan, China (2019-nCoV) has
expanded the number of highly pathogenic coronaviruses affecting
humans. The 2019-nCoV represents a potential epidemic or pandemic
threat, which requires a quick response for preparedness against this
infection. The present report uses the informational spectrum methodology
to identify the possible origin and natural host of the new virus, as well as
putative therapeutic and vaccine targets. The performed in silico analysis
indicates that the newly emerging 2019-nCoV is closely related to severe
acute respiratory syndrome (SARS)-CoV and, to a lesser degree, Middle
East respiratory syndrome (MERS)-CoV. Moreover, the well-known
SARS-CoV receptor (ACE2) might be a putative receptor for the novel virus
as well. Additional results indicated that civets and poultry are potential
candidates for the natural reservoir of the 2019-nCoV, and that domain
288-330 of S1 protein from the 2019-nCoV represents promising
therapeutic and/or vaccine target.
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Introduction
Fears are mounting worldwide over the cross-border spread of 
the new strain of coronavirus (denoted as 2019-nCoV) origi-
nated in Wuhan, the largest city in central China, after its spread 
to Thailand and Japan. The newly emerging pathogen belongs 
to the same virus family as the deadly severe acute respira-
tory syndrome and Middle East respiratory syndrome corona-
viruses (SARS-CoV and MERS-CoV, respectively). The World 
Health Organization (WHO) has recently published surveillance 
recommendations for a possible “large epidemic or even pan-
demic” of the novel coronavirus and it has issued guidelines 
for hospitals across the world. However, many questions about 
2019-nCov remain unanswered: (i) what is the origin and/or 
natural reservoir of the virus? (ii) is it easily transmitted from 
human to human? and (iii) what are the potential diagnos-
tic, therapeutic and vaccine targets? Currently, only nucleotide 
sequences of eight human 2019-nCoV isolates are avail-
able without any additional information about biological prop-
erties of the virus, beyond the morphology confirmation of the 
virion using electronic microscopy. This is likely not enough 
information to answer the important abovementioned questions. 
The informational spectrum method (ISM), a virtual spectros-
copy method for analysis of proteins, is based on the funda-
mental electronic properties of amino acids and requires only 
nucleotide sequence availability to investigate proteins1. For 
this reason, ISM was previously used for analysis of novel 
viruses for which little or no information were available2–5. Here, 
the 2019-nCoV was analyzed with ISM to identify its possi-
ble origin and natural host, as well as putative therapeutic and 
vaccine targets.
Methods
Sequences
The S1 surface protein sequences from 8 human 2019-nCoV, 
deposited in the publicly available GISAID database (assessed 
on January 19, 2020), were analyzed by ISM. The studied 
sequences were BetaCoV/Wuhan/IVDC-HB-04/2020, BetaCoV/
Wuhan/IVDC-HB-01/2019, BetaCoV/Wuhan/IVDC-HB-05/2019, 
BetaCoV/Wuhan/IPBCAMS-WH-01/2019, BetaCoV/Wuhan/
WIV04/2019, BetaCoV/Wuhan-Hu-1/2019, BetaCoV/Non-
thaburi/61/2020, and BetaCoV/Nonthaburi/74/2020.
In the phylogenetic analysis, different amino acid sequences 
of other coronaviruses were also included: (i) S1 proteins from 
the following viruses: AVP78042, AVPvp78031, AY304486, 
AY559093, JX163927, YN2018B, KY417146, used already by 
other authors in the study of the phylogenetic relationship between 
2019-nCoV and nearest bat and SARS-like CoVs (GISAID  
database); and (ii) S1 proteins from three first isolated human 
MERS-CoV: AGG22542, AFS88936, AFY13307, deposited 
in the GISAID database
The ISM
Detailed description of the sequence analysis based on ISM 
has been published elsewhere2. According to this approach, 
sequences (protein or DNA) are transformed into signals by 
assignment of numerical values of each element (amino acid 
or nucleotide). These values correspond to electron-ion inter-
action potential6, determining electronic properties of amino 
acid/nucleotides, which are essential for their intermolecu-
lar interactions. The signal obtained is then decomposed in a 
periodical function by the Fourier transformation. The result 
is a series of frequencies and their amplitudes. The obtained 
frequencies correspond to the distribution of structural motifs 
(primary structure) with defined physico-chemical character-
istics responsible for the biological function of the putative 
protein corresponding to the analyzed sequence. When compar-
ing proteins that share same biological or biochemical func-
tion, the technique allows detection of code/frequency pairs that 
are specific for their common biological properties. The 
method is insensitive to the location of the motifs and, there-
fore, does not require previous alignment of the sequences. 
In addition, this is the only method that allows immediate 
functional analysis.
Phylogenetic analysis
The phylogenetic tree of S1 proteins from coronaviruses was 
generated with the ISM-based phylogenetic algorithm ISTREE, 
previously described in detail elsewhere7. In the presented 
analysis, we calculated the distance matrix with the ampli-
tude on the frequency F(0.257) as the distance measure between 
sequences.
Results and discussion
In order to compare informational similarity between 2019-
nCoV, SARS-CoV, MERS-CoV and Bat SARS-like CoV, the 
cross-spectra (CS) of S1 proteins from these viruses were 
calculated. Figure 1a shows the CS of 2019-nCoV, SARS-CoV 
and MERS-CoV. These CS contain only one dominant peak 
corresponding to the frequency F(0.257). Figure 1b displays 
the CS of S1 proteins from 2019-nCoV and Bat SARS-like 
CoV. Amplitudes in these latter CS are significantly lower than 
in those CS presented in Figure 1a. These results show that 
(i) S1 proteins from 2019-nCoV, SARS-CoV, MERS-CoV and 
Bat SARS-like CoV encode common information, which is 
represented with the frequency F(0.257), and (ii) S1 proteins 
from 2019-nCoV are remarkable more informationally simi-
lar with S1 from SARS-CoV and MERS-CoV than with S1 
from Bat SARS-like CoV. This suggests that biological proper-
ties of 2019-nCoV are apparently more similar to SARS-CoV 
and MERS-CoV than to Bat SARS-like CoV.
To confirm this conclusion, the ISM-base phylogenetic tree 
for S1 proteins was calculated (Figure 2). In this calculation 
the amplitude on the frequency F(0.257) was used as the dis-
tance measure. As observed in Figure 2, all analyzed 2019-
nCoV S1 amino acid sequences are grouped with SARS-CoV 
and MERS-CoV and separated from Bat SARS-like CoV. This 
indicates that 2019-nCoV are more phylogenetically similar 
to SARS-CoV and MERS-CoV than to Bat SARS-like CoV. 
This result differs from those obtained with the homology-
based phylogenetic analysis, which showed that 2019-CoV are 
closely related to Bat SARS-like CoV (https://platform.gisaid.org/
epi3/frontend#lightbox1296857287).
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Figure 1. Cross-spectrum (CS) of S1 proteins. (a) CS of S1 from SARS-CoV, MERS-CoV and 2019-nCoV; (b) CS of Bat SARS-like CoV 
and 2019-NCov. The abscissa represents the frequencies from the Fourier transform of the sequence of electron-ion interaction potential 
corresponding to the amino-acid sequence of proteins. The lowest frequency is 0.0 and the highest is 0.5. The ordinate represents the signal-
to-noise ratio (the ratio between signal intensity at one particular IS frequency and the main value of the whole spectrum, S/N).
Figure 2. Informational spectrum method-based phylogenetic tree for S1 proteins from SARS-CoV, MERS-CoV, Bat SARS-like CoV 
and 2019-nCoV. The frequency F(0.257) as the distance measure was used.
It has been previously shown that the dominant frequency in 
the informational spectrum of viral envelope proteins corre-
sponds to interaction between the virus and its receptor2,3,7,8. The 
ISM analysis showed that the frequency component F(0.257) 
is present in the CS of S1 SARS-CoV and its receptor angi-
otensin converting enzyme 2 (ACE2)9, but not in the CS of S1 
MERS-CoV and its main receptor dipeptidyl peptidase 4 
(DPP4)10. Of note is that both receptors ACE2 and DPP4 are 
expressed in airway epithelia. Presence of F(0.257) in the infor-
mational spectrum of MERS-CoV (Figure 1) suggests also 
possible interaction between this virus and the ACE2. The 
dominant peak on the frequency F(0.257) in the CS of S1 from 
SARS-CoV and MERS-CoV and ACE2 supports this possibil-
ity (Figure 3), although this has not been formally proved for 
MERS-CoV11.
As it is shown in Figure 1a, the frequency F(0.257) is also 
present in the informational spectrum of the 2019-nCoV, 
suggesting that ACE2 might be the receptor for this novel 
coronavirus too. Calculation of the CS for S1 protein from the 
2019-nCoV and all ACE2 sequences available at the UniProt 
database revealed that the highest amplitudes on the frequency 
F(0.257) correspond to ACE2 from civet and chicken. This 
result indicates that these species can be included as potential 
candidates for the natural reservoir of the 2019-nCoV. How-
ever, it is possible that 2019-nCoV viruses use very different 
receptors in the natural host(s) and not only the ACE2 as it 
is the putative case in humans.
Finally, the S1 amino acid sequence from the 2019-nCoV was 
scanned to look for the domain that gives the highest contribu-
tion to the information represented by the frequency F(0.257) 
(Figure 4a). This analysis revealed domain 266–330 (number-
ing concerns the maturated protein) is essential for interaction 
of 2019-nCoV with ACE2. Of note is the striking homology 
between these domains of S1 proteins from 2019-nCoV and 
SARS-CoV, but not from MERS-CoV for which ACE2 is 
not the main receptor (Figure 4b).
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Figure 3. Cross-spectrum of ACE2 and S1 proteins from SARS-CoV and MERS-CoV. The abscissa and the ordinate are as described in 
Figure 1.
Figure 4. Domain of S1 protein which is important for 2019-nCoV/ACE2 interaction. (a) Mapping of the domain of S1 protein from 2019-
nCoV (BetaCoV/Wuhan/IVDC-HB-01/2019) which gives the dominant contribution to the information represented with the frequency F(0.257). 
(b) Sequence homology between domains of S1 proteins from SARS-CoV and 2019-nCoV with essential contribution to the information 
corresponding to the frequency F(0.257).
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In conclusion, results of the presented in silico analysis sug-
gest the following: (i) the newly emerging 2019-nCoV is 
highly related to SARS-CoV and, to a lesser degree, MERS-
CoV; (ii) civets and poultry are potential candidates for the 
natural reservoir of the 2019-nCoV and (iii) domain 
288–330 of S1 protein from the 2019-nCoV represents 
promising therapeutic and/or vaccine target. Further research 
on these issues are needed, including the development of 
reverse genetics and animal models to study the biology of 
2019-nCoV.
Data availability
Underlying data
Sequence data of the viruses were obtained from the GISAID 
EpiFlu™ Database. To access the database each individual 
user should complete the “Registration Form For Individual 
Users”, which is available alongside detailed instructions. After 
submission of the Registration form, the user will receive a 
password. There are not any other restrictions for the access 
to GISAID. Conditions of access to, and use of, the GISAID 
EpiFlu™ Database and Data are defined by the Terms of Use.
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